4846 |
NITRIC OXIDE SYNTHASE 3 |
NOS3 |
ECNOS |
eNOS |
163729 |
7876 |
ENSG00000164867 |
OTTHUMG00000158343 |
P29474 |
NOS3_HUMAN |
NITRIC-OXIDE SYNTHASE, ENDOTHELIAL (EC 1.14.13.39) (EC-NOS) (NOS, TYPE III) (NOSIII) (ENDOTHELIAL NOS) (ENOS) (CONSTITUTIVE NOS) (CNOS). [SOURCE:UNIPROT/SWISSPROT;ACC:P29474] |
PA254 |
NITRIC OXIDE SYNTHASE, ENDOTHELIAL |
Nitric-oxide synthase endothelial |
T06046 |
Target Class | Enzymes |
Target Subclass | EC:1.14.13.39 |
Target Subclass | 1.14.13.39 |
Target Main Class | Enzymes |
Human Readable Name | DRUGGABLE GENOME |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Domain |
Interpro Name | Oxidoreductase FAD/NAD(P)-binding |
Interpro Acc | IPR001433 |
Interpro Short Name | OxRdtase_FAD/NAD-bd |
Gene Biotype | PROTEIN_CODING |
DRUGGABLE GENOME |
n/a |
Novel drug target | Established target |
Trial Name | Sapropterin |
NOS3 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
ENSG00000164867 | Ensembl Gene Id |
NOS3 | Display Id |
NITRIC-OXIDE SYNTHASE, ENDOTHELIAL (EC 1.14.13.39) (EC-NOS) (NOS, TYPE III) (NOSIII) (ENDOTHELIAL NOS) (ENOS) (CONSTITUTIVE NOS) (CNOS). [SOURCE:UNIPROT/SWISSPROT;ACC:P29474] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ENSG00000164867 | Ensembl Gene Id |
P29474 | Uniprot Accession |
4846 | Entrez Gene Id |
Target Subclass | 1.14.13.39 |
Target Main Class | Enzymes |
NOS3 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:1.14.13.39 |
NOS3_HUMAN | Uniprot Id |
ENSG00000164867 | Ensembl Gene Id |
NITRIC OXIDE SYNTHASE, ENDOTHELIAL | Uniprot Protein Name |
Uniprot Status | Swiss-Prot |
Human Readable Name | DRUGGABLE GENOME |
Uniprot Evidence | 1: Evidence at protein level |
DRUGGABLE GENOME |
PA254 | PharmGKB ID |
ENSG00000164867 | Gene Symbol |
NOS3 | Ensembl Id |
DRUGGABLE GENOME |
NOS3 | TTD Gene Abbreviation |
T06046 | TTD Target ID |